HIV positive pregnant women receiving antiretrovirals, using in Namibia
Namibia: HIV positive pregnant women receiving antiretrovirals, using was 95.0% in 2011. ▲ Rising
HIV positive pregnant women receiving antiretrovirals, using in Namibia, 2004–2011
Source: http://data.unaids.org/pub/GlobalReport/2008/. Measured in %; high estimate.
Analysis
In 2011, hiv positive pregnant women receiving antiretrovirals, using in Namibia stood at 95.0%. That is the highest value across all 6 years on record.
The figure is up 578.6% over ten years.
That places Namibia 1st out of 38 countries with data for 2011, putting it in the top 10%.
HIV positive pregnant women receiving antiretrovirals, using in Namibia, year by year
| Year | %; high estimate | Change |
|---|---|---|
| 2004 | 14.0% | — |
| 2005 | 52.0% | +271.4% |
| 2006 | 79.0% | +51.9% |
| 2007 | 80.0% | +1.3% |
| 2009 | 95.0% | +18.8% |
| 2011 | 95.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 64.0% | 14.0% | 95.0% | 5 |
| 2010s | 95.0% | 95.0% | 95.0% | 1 |
Countries ranked near Namibia
More health data for Namibia
- Un projection of annual infant deaths, annual growth rate -1.75 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6445 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,046 deaths per 1,000 people (2090)
- Number of infants who die before age 1 561 deaths (2100)
- Population ages 05-09, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 05-09, female, per capita 0.0637 units per person (2025)
- Population ages 05-09, male, annual growth rate 2.55 % change on previous year (2025)
- Population ages 05-09, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 05-09, male, per capita 0.0632 units per person (2025)
- Population ages 10-14, female, annual growth rate 3.1 % change on previous year (2025)
Frequently asked questions
- What is hiv positive pregnant women receiving antiretrovirals, using in Namibia?
- Hiv positive pregnant women receiving antiretrovirals, using in Namibia was 95.0% in 2011, according to http://data.unaids.org/pub/GlobalReport/2008/.
- What is the highest hiv positive pregnant women receiving antiretrovirals, using recorded in Namibia?
- The highest recorded value was 95.0% in 2009.
- What is the lowest hiv positive pregnant women receiving antiretrovirals, using recorded in Namibia?
- The lowest recorded value was 14.0% in 2004.
- How does Namibia rank for hiv positive pregnant women receiving antiretrovirals, using?
- Namibia ranks 1st out of 38 countries with data for 2011.
- Is hiv positive pregnant women receiving antiretrovirals, using rising or falling in Namibia?
- Over the last ten years it is up 578.6%. The long-run trend across the full record is rising.
- Where does this Namibia data come from?
- The figures come from http://data.unaids.org/pub/GlobalReport/2008/, published as part of HIV positive pregnant women receiving antiretrovirals, using WHO/UNAIDS methodology (%; high estimate). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Percentage of HIV-infected pregnant women who received antiretrovirals to reduce the risk of mother-to-child transmission. Numerator: Number of HIV-infected pregnant women who received antiretrovirals during the last 12 months to reduce mother-to-child transmission. Denominator: Estimated number of HIV-infected pregnant women in the last 12 months. Ranges are presented for countries with low and concentrated epidemics. The purpose of this indicator is to assess progress in preventing vertical transmission of HIV. All data reflect values representing 12 month period ending December 2007 which have been reconciled between reporting country and UNAIDS/WHO/UNICEF, unless otherwise noted. All analysis of this indicator, including quoted country figures, reflect numerators which have gone through a tri agency reconciliation (UNAIDS/WHO/UNICEF) process and denominators which have been estimated directly from the UNAIDS/WHO Reference group on Estimates, Modelling and Projections methodology (Spectrum). The reconciliation process ensured all agencies reported the same country endorsed figure which was the most recent and met the definition of HIV-infected women receiving antiretroviral drugs over the last 12 months, and thus reflect a full year. Every effort was made in cases of discrepancy across the three agencies to obtain approval from the country on a final indicator value.